Synonyms: BAY8002
Compound class:
Synthetic organic
Comment: BAY-8002 inhibits lactate transport via the monocarboxylate transporter 1 (MCT1: SLC16A1) [1]. [3H]-BAY-8002 binds to MCT1 with a Kd of 7.9 nM.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
As lactate transport is essential for cancer cell metabolism, pharmacological inhibitors of the high-affinity lactate transporter MCT1, are considered to offer potential for cancer therapy. BAY8002 is potent inhibitor of MCT1-dependent bidirectional lactate transport, however it exhibits limited antitumour efficacy in vivo [1]. BAY8002 inhibits lactate uptake in MCT2-expressing oocytes, with approximately 5-fold lower potency compared with the MCT1 isoform, but is inactive at MCT4, which is indicative of this compound being a dual MCT1/2 inhibitor. |
Selectivity at transporters | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|